Canagliflozin reprograms the aging hippocampus in genetically diverse UM-HET3 mice and attenuates Alzheimer's-like pathology
The goal is to asses the effect of Canagliflozin on the hippocampus of UM-HET3 mice at 12 and 25 months of age. Mice were fed with Canagliflozin from 7 months of age.